Ionic currents and ventricular fibrillation dynamics;Corrientes iónicas y dinámica de la fibrilación ventricular

Revista Espanola de Cardiologia

Volumn 57, Issue 1, 2004, Pages 69-79

  Moreno, Javier ^a,b   Warren, Mark ^b   Jalife, José ^b  

^a HOSPITAL CLÍNICO SAN CARLOS   (Spain)

^b SUNY UPSTATE MEDICAL UNIVERSITY   (United States)

Author keywords

Antiarrhythmics agents; Fibrillation; Ions

Indexed keywords

AMIODARONE; ANTIARRHYTHMIC AGENT; BETA ADRENERGIC RECEPTOR BLOCKING AGENT; CALCIUM ANTAGONIST; DOFETILIDE; FLECAINIDE; IBUTILIDE; LIDOCAINE; PILSICAINIDE; PLACEBO; PROCAINAMIDE; PROPAFENONE; SOTALOL; VERAPAMIL;

DRUG EFFICACY; DRUG RESEARCH; DRUG SELECTIVITY; DYNAMICS; ELECTRIC CONDUCTIVITY; ELECTROSTIMULATION; HEART ARRHYTHMIA; HEART ELECTROPHYSIOLOGY; HEART MUSCLE; HEART MUSCLE CELL; HEART VENTRICLE FIBRILLATION; HUMAN; ION CURRENT; MEMBRANE CONDUCTANCE; NONLINEAR SYSTEM; PATHOPHYSIOLOGY; REVIEW; SUDDEN DEATH; THEORY; TREATMENT OUTCOME;

EID: 1442280695     PISSN: 03008932     EISSN: None     Source Type: Journal    
DOI: 10.1157/13056510     Document Type: Review

References (70)

1. Lal R, Chapman PD, Naccarelli GV, Schechtman KB, Rinkenberger RL, Troup PJ, et al. Flecainide in the treatment of nonsustained ventricular tachycardia. Ann Intern Med 1986;105:493-8.
2. Salerno DM, Gillingham KJ, Berry DA, Hodges M. A comparison of antiarrhythmic drugs for the suppression of ventricular ectopic depolarizations: a meta-analysis. Am Heart J 1990;120:340-53.
3. Cairns JA, Connolly SJ, Roberts R, Gent M. Randomised trial of outcome after myocardial infarction in patients with frequent or repetitive ventricular premature depolarisations: CAMIAT. Canadian Amiodarone Myocardial Infarction Arrhythmia Trial Investigators. Lancet 1997;349:675-82.
4. Julian DG, Camm AJ, Frangin G, Janse MJ, Munoz A, Schwartz PJ, et al. Randomised trial of effect of amiodarone on mortality in patients with left-ventricular dysfunction after recent myocardial infarction: EMIAT. European Myocardial Infarct Amiodarone Trial Investigators. Lancet 1997;349:667-74.
5. Kober L, Bloch Thomsen PE, Moller M, Torp-Pedersen C, Carlsen J, Sandoe E, et al. Effect of dofetilide in patients with recent myocardial infarction and left-ventricular dysfunction: a randomised trial. Lancet 2000;356:2052-8.
6. Ruskin JN. The cardiac arrhythmia suppression trial (CAST). N Engl J Med 1989;321:386-8.
7. Morganroth J, Goin JE. Quinidine-related mortality in the short-to-medium-term treatment of ventricular arrhythmias. A meta-analysis. Circulation 1991;84:1977-83.
8. Berntsen RF, Rasmussen K. Lidocaine to prevent ventricular fibrillation in the prehospital phase of suspected acute myocardial infarction: the North-Norwegian Lidocaine Intervention Trial. Am Heart J 1992;124:1478-83.
9. Waldo AL, Camm AJ, DeRuyter H, Friedman PL, MacNeil DJ, Pauls JF, et al. Effect of d-sotalol on mortality in patients with left ventricular dysfunction after recent and remote myocardial infarction. The SWORD Investigators. Survival With Oral d-Sotalol. Lancet 1996;348:7-12.
10. The Cardiac Insufficiency Hisoprolol Study II (CIBIS-II): a randomised trial. Lancet 1999;353:9-13.
11. Effect of metoprolol CR/XL in chronic heart failure: Metoprolol CR/XL Randomised Intervention Trial in Congestive Heart Failure (MERIT-HF). Lancet 1999;353:2001-7.
12. Pachón IM, Jalife J. Nuevos conceptos sobre los mecanismos de la fibrilación ventricular. Rev Esp Cardiol 2001;54:373-82.
13. Davidenko JM, Pertsov AV, Salomonsz R, Baxter W, Jalife J. Stationary and drifting spiral waves of excitation in isolated cardiac muscle. Nature 1992;355:349-51.
14. Pertsov AM, Davidenko JM, Salomonsz R, Baxter WT, Jalife J. Spiral waves of excitation underlie reentrant activity in isolated cardiac muscle. Circ Res 1993;72:631-50.
15. Gray RA, Jalife J, Panfilov AV, Baxter WT, Cabo C, Davidenko JM, et al. Mechanisms of cardiac fibrillation. Science 1995;270: 1222-3.
16. Winfree AT. Stably rotating patterns of reaction and diffusion. Prog Theor Chem 1978;4:1-51.
17. Winfree AT. When time breaks down. New Jersey: Princeton Univ Press, 1987; p. 108-10.
18. Zykov VS. Analytic evaluation of the relationship between the speed of a wave of excitation in a two-dimensional excitable medium and the curvature of its front. Biofizika 1980;25:888-92.
19. Pertsov AM, Khramov RN, Panfilov AV. Sharp increase in refractory period induced by oxidation suppression in Fitz Hugh-Nagumo model. New mechanism of antiarrhythmic drug action. Biofizika 1981;26:1077-81.
20. Chorro FJ, Millet J, Ferrero A, Cebrian A, Canoves J, Martinez A. Efecto del estiramiento miocárdico sobre las frecuencias de activación determinadas mediante análisis espectral durante la fibrilación ventricular. Rev Esp Cardiol 2002;55:1143-50.
21. Beaumont J, Davidenko N, Davidenko JM, Jalife J. Spiral waves in two-dimensional models of ventricular muscle: formation of a stationary core. Biophys J 1998;75:1-14.
22. Beaumont J, Jalife J. Rotors and spiral waves in two dimensions. En: Zipes DP, Jalife J, editors. Cardiac electrophysiology from cell to bedside. Philadelphia: Saunders, 2000; p. 327-35.
23. Moe GK. On the multiple wavelet hypothesis of atrial fibrillation. Arch Int Pharmacodyn Ther 1962;140:183-8.
24. Karma A. Electrical alternans and spiral wave breakup in cardiac tissue. Chaos 1994;4:461-72.
25. Garfinkel A, Kim YH, Voroshilovsky O, Qu Z, Kil JR, Lee MH, et al. Preventing ventricular fibrillation by flattening cardiac restitution. Proc Natl Acad Sci USA 2000;97:6061-6.
26. Riccio ML, Koller ML, Gilmour RF. Electrical restitution and spatiotemporal organization during ventricular fibrillation. Circ Res 1999;84:955-63.
27. Gray RA, Pertsov AM, Jalife J. Spatial and temporal organization during cardiac fibrillation. Nature 1998;392:75-8.
28. Jalife J, Berenfeld O, Skanes A, Mandapati R. Mechanisms of atrial fibrillation: mother rotors or multiple daughter wavelets, or both? J Cardiovasc Electrophysiol 1998;9:S2-12.
29. Weidmann S. The electrical constants of Purkinje fibres. J Physiol 1952;118:348-60.
30. Mandapati R, Asano Y, Baxter WT, Gray R, Davidenko J, Jalife J. Quantification of effects of global ischemia on dynamics of ventricular fibrillation in isolated rabbit heart. Circulation 1998;98:1688-96.
31. Coraboeuf E, Deroubaix E. Shortening effect of tetrodotoxin on action potentials of the conducting system in the dog heart. J Physiol 1978;280:P24.
32. Cabo C, Pertsov AM, Baxter WT, Davidenko JM, Gray RA, Jalife J. Wave-front curvature as a cause of slow conduction and block in isolated cardiac muscle. Circ Res 1994;75:1014-28.
33. Krinsky VI, Efimov IR, Jalife J. Vortices with linear cores in excitable media. Proc R Soc Lond 1992;437:645-55.
34. Kwan YY, Fan W, Hough D, Lee JJ, Fishbein MC, Karagueuzian HS, et al. Effects of procainamide on wave-front dynamics during ventricular fibrillation in open-chest dogs. Circulation 1998; 97:1828-36.
35. Starmer CF, Lastra AA, Nesterenko VV, Grant AO. Proarrhythmic response to sodium channel blockade. Theoretical model and numerical experiments. Circulation 1991;84:1364-77.
36. Akiyama T. Intracellular recording of in situ ventricular cells during ventricular fibrillation. Am J Physiol 1981;240:H465-71.
37. Zhou X, Guse P, Wolf PD, Rollins DL, Smith WM, Ideker RE. Existence of both fast and slow channel activity during the early stages of ventricular fibrillation. Circ Res 1992;70:773-86.
38. Duff HJ, Sheldon RS, Cannon NJ. Tetrodotoxin: sodium channel specific anti-arrhythmic activity. Cardiovasc Res 1988;22:800-7.
39. Starmer CF, Lancaster AR, Lastra AA, Grant AO. Cardiac instability amplified by use-dependent Na channel blockade. Am J Physiol 1992;262:H1305-10.
40. Herre JM, Titus C, Oeff M, Eldar M, Franz MR, Griffin JC, et al. Inefficacy and proarrhythmic effects of flecainide and encainide for sustained ventricular tachycardia and ventricular fibrillation. Ann Intern Med 1990;113:671-6.
41. Balke CW, Marbán E, O'Rourke B. Calcium channels: structure, function and regulation. En: Zipes DP, Jalife J, editors. Cardiac electrophysiology. From cell to bedside. Philadelphia: Saunders, 2000; p. 8-21.
42. Noguchi K, Masumiya H, Takahashi K, Kaneko K, Higuchi S, Tanaka H, et al. Comparative effects of gallopamil and verapamil on the mechanical and electrophysiological parameters of isolated guinea-pig myocardium. Can J Physiol Pharmacol 1997;75:1316-21.
43. Watanabe T, Gray RA, Mandapati R, Asano T, Jalife J. Verapamil converts fibrillation into sustained monomorphic tachycardia in the isolated rabbit heart. Pacing Clin Electrophysiol 1997;20: 1136.
44. Samie FH, Mandapati R, Gray RA, Watanabe Y, Zuur C, Beaumont J, et al. A mechanism of transition from ventricular fibrillation to tachycardia: effect of calcium channel blockade on the dynamics of rotating waves. Circ Res 2000;86:684-91.
45. Choi BR, Nho W, Liu T, Salama G. Life span of ventricular fibrillation frequencies. Circ Res 2002;91:339-45.
46. Wu TJ, Lin SF, Weiss JN, Ting CT, Chen PS. Two types of ventricular fibrillation in isolated rabbit hearts: importance of excitability and action potential duration restitution. Circulation 2002; 106:1859-66.
47. Wagner JA, Weisman HF, Levine JH, Snowman AM, Snyder SH. Differential effects of amiodarone and desethylamiodarone on calcium antagonist receptors. J Cardiovasc Pharmacol 1990;15: 501-7.
48. Omichi C, Zhou S, Lee MH, Naik A, Chang CM, Garfinkel A, et al. Effects of amiodarone on wave front dynamics during ventricular fibrillation in isolated swine right ventricle. Am J Physiol Heart Circ Physiol 2002;282:H1063-70.
49. Chorro FJ, Canoves J, Guerrero J, Mainar L, Sanchis J, Such L, et al. Alteration of ventricular fibrillation by flecainide, verapamil, and sotalol: an experimental study. Circulation 2000;101:1606-15.
50. Andersen HR, Wiggers H, Knudsen LL, Simonsen I, Thomsen PE, Christiansen N. Dofetilide reduces the incidence of ventricular fibrillation during acute myocardial ischaemia. A randomised study in pigs. Cardiovasc Res 1994;28:1635-40.
51. Xue Y, Yamada C, Chino D, Hashimoto K. Effects of azimilide, a KV(r) and KV(s) blocker, on canine ventricular arrhythmia models. Eur J Pharmacol 1999;376:27-35.
52. Dorian P, Newman D. Tedisamil increases coherence during ventricular fibrillation and decreases defibrillation energy requirements. Cardiovasc Res 1997;33:485-94.
53. Choi BR, LIu T, Salama G. The distribution of refrachory periods influence the dynamics of ventricular fibrillation. Circ Res 2001; 88: E49.
54. Qi XQ, Newman D, Dorian P. Azimilide decreases defibrillation voltage requirements and increases spatial organization during ventricular fibrillation. J Interv Card Electrophysiol 1999;3:61-7.
55. Uchida T, Yashima M, Gotoh M, Qu Z, Garfinkel A, Weiss JN, et al. Mechanism of acceleration of functional reentry in the ventricle: effects of ATP-sensitive potassium channel opener. Circulation 1999;99:704-12.
56. Chi L, Uprichard AC, Lucchesi BR. Profibrillatory actions of pinacidil in a conscious canine model of sudden coronary death. J Cardiovasc Pharmacol 1990;15:452-64.
57. Robert E, Delye B, Aya G, Peray P, Juan JM, Sassine A, et al. Comparison of proarrhythmogenic effects of two potassium channel openers, levcromakalim and nicorandil: a high-resolution mapping study on rabbit heart. J Cardiovasc Pharmacol 1997;29: 109-18.
58. Pertsov AM, Panfilov AV, Medvedeva FU. Instabilities of autowaves in excitable media associated with critical curvature phenomena. Biofizika 1983;28:100-2.
59. Nichols CG, Lopatin AN. Inward rectifier potassium channels. Annu Rev Physiol 1997;59:171-91.
60. Yang J, Jan YN, Jan LY. Control of rectification and permeation by residues in two distinct domains in an inward rectifier K+ channel. Neuron 1995;14:1047-54.
61. Samie FH, Berenfeld O, Anumonwo J, Mironov SF, Udassi S, Beaumont J, et al. Rectification of the background potassium current: a determinant of rotor dynamics in ventricular fibrillation. Circ Res 2001;89:1216-23.
62. Warren M, Guha PK, Berenfeld O, Zaitsev A, Anumonwo JMB, Dhamoon AS, et al. Blockade of the inward rectifying potassium current terminates ventricular fibrillation in the guinea pig heart. J Cardiovasc Electrophysiol 2003;14:621-31.
63. Dhamoon AS, Bagwe S, Guha P, Anumonwo JM, Taffet SM, Jalife J. Differential expression and whole-cell current rectification profiles of guinea pig Kir2.x channels. Biophys J 2002;82:587a.
64. Kubo Y, Baldwin TJ, Jan YN, Jan LY. Primary structure and functional expression of a mouse inward rectifier potassium channel. Nature 1993;362:127-33.
65. Dorian P, Penkoske PA, Witkowski FX. Order in disorder: effect of barium on ventricular fibrillation. Can J Cardiol 1996;12:399-406.
66. Kudenchuk PJ, Cobb LA, Copass MK, Cummins RO, Doherty AM, Fahrenbruch CE, et al. Amiodarone for resuscitation after out-of-hospital cardiac arrest due to ventricular fibrillation. N Engl J Med 1999;341:871-8.
67. Ramírez CJ, Rodríguez DA, Velasco VM, Rosas F. Distrofia miotónica y taquicardia ventricular por reentrada rama-rama. Rev Esp Cardiol 2002;55:1093-7.
68. Zaitsev AV, Guha PK, Sarmast F, Kolli A, Berenfeld O, Pertsov AM, et al. Wavebreak formation during ventricular fibrillation in the isolated, regionally ischemic pig heart. Circ Res 2003;92:546-53.
69. Fuster V, Ryden LE, Asinger RW, Cannom DS, Crijns HJ, Frye RL, et al. ACC/AHA/ESC guidelines for the management of patients with atrial fibrillation. J Am Coll Cardiol 2001;38:1231-66.
70. Atarashi H, Inoue H, Hiejima K, Hayakawa H. Conversion of recent-onset atrial fibrillation by a single oral dose of pilsicainide. The PSTAF Investigators. Am J Cardiol 1996;78:694-7.